Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
주식 순위 #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$2.62K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Anthera Pharmaceuticals, Inc. (ANTH)

카테고리

Anthera Pharmaceuticals, Inc. (ANTH)의 주가 이력
최고 종가: $0.00 (2026-08-01 기준)

최저 종가: $450.76 (2010-03-01 기준)
Anthera Pharmaceuticals, Inc.의 주가 이력 (2010 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 0.00%
2025 -18.71%
2024 -4.67%
2023 0.00%
2022 -15.38%
2021 -99.38%
2020 -48.36%
2019 -0.60%
2018 -97.65%
2017 -88.08%
2016 -65.41%
2015 166.78%
2014 -38.48%
2013 -45.84%
2012 -89.34%
2011 26.69%
2010 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$1.08K -6.44%
KR
$263.09 18.09%
BE